Linda Palczuk Avadel Pharmaceuticals PLC (AVDL) insider trading activity

Linda Palczuk is Director of AVADEL PHARMACEUTICALS PLC. Currently has a direct ownership of 78,900 shares of AVDL, which is worth approximately $1.21 Million. The most recent transaction as insider was on Jul 29, 2025, when has been sold 11,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 78.9K

16.2% 3M change

24.45% 12M change

Total Value Held $1.21 Million

Linda Palczuk Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 29 2025	BUY Grant, award, or other acquisition	-	11,000 Added 12.24%	78,900 Ordinary Shares
Jan 21 2025	BUY Open market or private purchase	$39,650 $7.93 p/Share	5,000 Added 6.86%	67,900 Ordinary Shares
Dec 24 2024	SELL Bona fide gift	-	3,500 Reduced 5.27%	62,900 Ordinary Shares
Dec 06 2024	BUY Open market or private purchase	$30,570 $10.19 p/Share	3,000 Added 4.32%	66,400 Ordinary Shares
Jul 30 2024	BUY Grant, award, or other acquisition	-	11,000 Added 14.78%	63,400 Ordinary Shares
May 09 2023	BUY Open market or private purchase	$36,900 $14.76 p/Share	2,500 Added 4.55%	52,400 ADSs
Dec 23 2022	BUY Open market or private purchase	$14,400 $7.2 p/Share	2,000 Added 3.85%	49,900 ADSs
May 27 2022	BUY Open market or private purchase	$16,000 $1.6 p/Share	10,000 Added 17.27%	47,900 ADSs

Linda Palczuk

Director

Dublin 2, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVDL shares.

Notify only if

Value

Insider Trading

Get notified when an Avadel Pharmaceuticals PLC insider buys or sells AVDL shares.

Notify only if

Operation

Value

Type

News

Receive news related to AVADEL PHARMACEUTICALS PLC

Track Activities on AVDL

Account